News
Centenarians had lower disease burden, particularly for CVD, delayed onset of multiple conditions, and fewer cooccurring diseases over time.
Women who reported experiencing stalking had a 1.4 times increased risk for self-reported incident cardiovascular disease. HealthDay News — Women who report experiencing stalking and obtaining a ...
Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.
Trump is mandating that grants only be approved if they align with his priorities, federal agency priorities, and the “national interest.” ...
The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.
Many Americans are unaware of human papillomavirus, the availability of HPV vaccination, and HPV-associated cancers.
New pill orforglipron was associated with a significant reduction in body weight and better cholesterol, triglycerides and blood pressure.
Patients with psoriasis without musculoskeletal involvement are 2.5 times more likely to have synovitis on imaging than control patients.
The prevalence of drinking alcohol in the US has declined in recent years while belief that drinking is unhealthy has increased.
The management of infantile hemangioma has changed in recent years, shifting from an observation-based approach to active treatment in most patients.
ESK-001, a novel therapy for moderate to severe plaque psoriasis, had acceptable safety and efficacy outcomes at 12 weeks of treatment.
Topline results were announced from a phase 3 trial evaluating Cylembio (imsapepimut and etimupepimut, adjuvanted) in combination with pembrolizumab as a first-line treatment for advanced melanoma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results